Actively Recruiting
Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes
Led by Yale University · Updated on 2025-11-06
60
Participants Needed
1
Research Sites
103 weeks
Total Duration
On this page
Sponsors
Y
Yale University
Lead Sponsor
N
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The challenges of living with type 1 diabetes often stand in the way of getting enough exercise. Continuous blood sugar monitoring has revolutionized type 1 diabetes care but remains underutilized to sustainably support exercise and related behaviors. This remote participation-based research will develop a mobile application that delivers personalized encouragement and data-driven health insights based upon patterns in blood sugar, exercise, mood, and sleep, to assist people with type 1 diabetes in exercising more frequently and confidently. You do not need to live in Connecticut to participate, as there will be no required in-person visits during the study.
CONDITIONS
Official Title
Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 30 to 65 years inclusive
- Diagnosed with type 1 diabetes or other insulin deficiency diabetes including latent autoimmune diabetes of adulthood or diabetes secondary to pancreatitis
- Exercising less than 1.0 sessions per week
- Owns a smartphone
- Able to read and understand English
- Under regular care by a healthcare provider with at least one appointment per year
- Has home broadband internet or cell phone network access
- Using a continuous glucose monitor and sharing data with medical records for at least 6 weeks
- Using an insulin pump or pen and sharing data with medical records for at least 6 weeks
You will not qualify if you...
- Diabetic ketoacidosis unrelated to pump site failure within the past 6 months
- More than one episode of severe hypoglycemia requiring assistance in the past 6 months
- Hemoglobin A1c equal to or greater than 10.0%
- Resting blood pressure above 160 mmHg systolic or 100 mmHg diastolic
- Myocardial infarction or angina within the past 12 months
- Uncontrolled arrhythmia such as atrial fibrillation or ventricular tachycardia
- Congestive heart failure stage 3 or 4
- Exercise-induced asthma not controlled by inhalers
- Chronic obstructive pulmonary disease requiring home oxygen
- Renal failure
- Pregnancy
- Cognitive impairment
- Severe retinopathy or neuropathy
- Other chronic disease or physical disability affecting ability to exercise, such as recent spinal surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Yale School of Medicine
New Haven, Connecticut, United States, 06510
Actively Recruiting
Research Team
Y
Yashvi Verma, BS
CONTACT
G
Garrett Ash, PhD, CSCS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
CROSSOVER
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here